Importance of package insert information in the European union: Medicinal and pharmaceutical experts questioning results

Pharmazeutische Industrie

Volumn 69, Issue 2, 2007, Pages 165-172

  Fuchs, Jörg ^a,b   Banow, Stefanie ^c   Görbert, Nancy ^c   Hippius, P D Marion ^c  

^a PAINT Consult   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG INFORMATION; DRUG SAFETY; EUROPEAN UNION; HUMAN; MEDICAL INFORMATION; MEDICAL PRACTICE; PHARMACEUTICAL CARE;

EID: 34247176387     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Council of the European Communities, Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets. OJ 1992;L 113:107.
2. Puteanus U. Arzneimittelwerbung - Verbraucher wollen Information. Gesundheitswesen 2000;62:516.
3. Van der Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. Annals of Pharmacotherapy 1991;25:1002.
4. Fuchs J, Hippius M, Schaefer M. A survey of package inserts use by patients. Hospital Pharmacy Europe 2005;21:29.
5. EMEA, QRD Working Group - Guidance of implementation, MR/DC/Referral Procedures Version 1.1 (June 2006) http://www.emea.eu.int/htms/human/qrd/ qrdtemplate.htm, 10 August 2006.
6. European Commission, A guideline on the readability of the label and package leaflet of medicinal products for human use, Brussels, 29 September 1998. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-2/c/ gl981002.pdf, 29 September 2006.
7. European Commission, Draft - Guideline on the readability of the label and package leaflet of medicinal products for human use, Revision September 2006. http://ec.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/doc2006/ 09_2006/readability_consultation_2006_09_ 25.pdf, 2 October 2006.
8. European Parliament and Council of the European Union, Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. OJ 2001;L 311:67.
9. European Parliament and Council of the European Union, Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 on the Community code relating to medicinal products for human use. OJ 2004;L136:34.
10. European Commission, Guidance concerning consultations with target patient groups for the package leaflet, May 2006 http://ec.europa.eu/ enterprise/pharmaceuticals/eudralex/vol-2/c/user_consultation_200605.pdf, 24 May 2006.
11. Sless D, Wiseman R. Writing about medicines for people: usability guidelines for consumer medicine information. Department of Health and Family Services, Canberra (1997).
12. EFPIA Draft document, Status of implementation of the European Union pharmaceutical legislation at member state level, Date: 20 September 2006. Circular No 11.975 (2006).
13. Repräsentativbefragung zum Thema "Beipackzettel von Medikamenten und Beratung", GfK-Marktforschung, Nürnberg (2003).
14. Fuchs J, Hippius M, Schaefer M. Gestaltung von Packungsbeilagen für Arzneimittel. Pharm Ind. 2003; 65:302.
15. Berry DC, Michas IC, Gillie T. Forster M. What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychology and Health 1997;12:467.
16. Müller U. Optimierung der Arzneimittelinformation zur Verbesserung der Arzneimittelsicherheit und der Qualität - Zur Notwendigkeit der Implementierung und Nutzung von Fachinformationen in der täglichen ambulanten Verordnungspraxis (Optimizing pharmaceutical product information to improve drug safety and quality - In relation to the necessity to implement and use SmPCs in daily outpatient prescribing practice), dissertation, University of Bremen (2006).
17. Bernardini C, Ambrogie V, Perioli L et al. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms. Pharmacological Research 2000;41:679.
18. Weitbrecht W-U, Voßkämper C. Influence of the drug package information paper on compliance of neurological and psychiatric outpatients. Fortschr Neurol Psychiatr. 2002;4:178.
19. Fuchs J. Die Packungsbeilagen als ein Mittel zur gezielten Information und Handlungsanleitung für Patienten - Entwicklung und Testung eines Instrumentes zur Beurteilung und Optimierung der Packungsbeilagen von Arzneimitteln (Package inserts as medium to convey targeted information and directions for use to patients: Developing and testing a tool to rate and optimize pharmaceutical product package inserts), dissertation, Humboldt University, Berlin (2005).
20. Fuchs J. Entwicklung und Testung eines Instrumentes zur Beurteilung und Optimierung von Packungsbeilagen. http://www.bfarm.de/nn_599148/SharedDocs/ Publikationen/DE/BfArM/publ/praesent/vortraege/dialog-060215/vortrag_fuchs, templateId=raw,property=publication File.pdf/vortrag_fuchs.pdf, 7 July 2006.
21. Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz, AMG) in der Fassung vom 12. Dezember 2005. BGBl. I, 73 (2005) (German drug law as of 12 December 2005).
22. Fuchs J, Hippius M, Schaefer M. Analysis of German package inserts. Int J Clin Pharmacol. Ther. 2006;44:8.
23. Bernadini C, Ambrogi V, Fardella G, Perioli L, Grandolini G. How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout. Pharmacological Research 2001;5: 437.
24. Kienzl H, Kleinsorge H, Schaaf HP. Patientengerechte Gebrauchsinformation für Arzneimittel - Entwicklung eines Modells. Gustav Fischer Verlag, Stuttgart-New York (1987).
25. Boyce PR. Human Factors in Lighting. Applied Science Puplishers, London (1981).
26. Bundesinstitut für Arzneimittel und Medizinprodukte, Bekanntmachung über die Neufassung der Empfehlungen zur Gestaltung von Pakkungsbeilagen nach § 11 des Arzneimittelgesetzes (AMG) für Humanarzneimittel, 15. März 2002. BAnz. 2002;78:9083.
27. Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz) in der Fassung der Neubekanntmachung, 11. Dezember 1998. BGBl. I 3586 (1998) (German drug law as of 11 December 1998).